More on Communicating Science

This note is in response to Saul Green,1 who was responding to Mary Woolley's call for scientists to reach out to nonscientists.2 Green says he and his colleagues have been trying to do this for many years but without apparent success. I believe I can see why. It is not, as he implies, the "closedness" of those who, for example, believe in homeopathy and are therefore unresponsive to scientific refutation of that belief system. Rather it appears to be the mutual "closedness" of two distinct beli

Written byMichael R.olson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This note is in response to Saul Green,1 who was responding to Mary Woolley's call for scientists to reach out to nonscientists.2 Green says he and his colleagues have been trying to do this for many years but without apparent success. I believe I can see why. It is not, as he implies, the "closedness" of those who, for example, believe in homeopathy and are therefore unresponsive to scientific refutation of that belief system. Rather it appears to be the mutual "closedness" of two distinct belief systems. Green, the believer in the rightness of the scientific view that homeopathy is malarkey, is disconcerted in not being able to rehabilitate the believer in homeopathy and probably vice versa. In this situation, there can and will be no communication.

To get communication started requires each viewpoint to set aside its "true beliefs" and look for a common ground for communication. "Scientific truths" ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies